ANTICORPS ANTI-CD154 AYANT UNE LIAISON DETERIOREE AU FCR ET/OU DES PROPRIETES DE LIAISON AU COMPLEMENT DETERIOREE ET LEUR UTILISATION DANS DES THERAPIES IMMUNOLOGIQUES
Improved anti-CD154 antibodies are provided herein which have ablated FcR binding. The use of these antibodies for inducing tolerance and treating immune diseases including autoimmunity, inflammation and allergic disorders is disclosed herein.